Fig. 3From: International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)a Distribution of CHADS2 b CHA2DS2-VASc and c HAS-BLED scores in RIVER registryBack to article page